Skip to main content
. 2022 Dec 15;22:321. doi: 10.1186/s12874-022-01769-5

Table 3.

Comparison of treatment groups in each trial, before and after weighting. SoC: Standard of Care; DXM: dexamethasone

Group SoC High DXM High DXM weighted Low DXM
Age, mean ± SD 65.2 ± 11.0 66.1 ± 10.7 58.8 ± 10.7 58.8 ± 11.3
Male sex, % 72.5% 80.4% 72.0% 72.0%
Comorbidities, % 74.3% 70.1% 49.0% 49.0%